Defective interaction between p27 and cyclin A-CDK complex in certain human cancer cell lines revealed by split YFP assay in living cells

References

• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501–1512.10.1101/gad.13.12.1501
   PubMed Web of Science ®Google Scholar
• Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14:159–169.10.1016/j.devcel.2008.01.013
   PubMed Web of Science ®Google Scholar
• Lu Z, Hunter T. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle. 2010;9:2342–2352.10.4161/cc.9.12.11988
   PubMed Web of Science ®Google Scholar
• Servant MJ, Coulombe P, Turgeon B, et al. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol. 2000;148:543–556.10.1083/jcb.148.3.543
   PubMed Web of Science ®Google Scholar
• Garrett-Engele CM, Tasch MA, Hwang HC, et al. A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet. 2007;3:e219.10.1371/journal.pgen.0030219
   PubMed Web of Science ®Google Scholar
• Hengst L, Reed SI. Translational control of p27Kip1 accumulation during the cell cycle. Science. 1996;271:1861–1864.10.1126/science.271.5257.1861
   PubMed Web of Science ®Google Scholar
• Millard SS, Yan JS, Nguyen H, et al. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem. 1997;272:7093–7098.10.1074/jbc.272.11.7093
   PubMed Web of Science ®Google Scholar
• Le Sage C, Nagel R, Agami R. Diverse ways to control p27Kip1 function: miRNAs come into play. Cell Cycle. 2007;6:2742–2749.10.4161/cc.6.22.4900
   PubMed Web of Science ®Google Scholar
• Viglietto G, Motti ML, Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle. 2002;1:394–400.10.4161/cc.1.6.263
   PubMed Web of Science ®Google Scholar
• Slingerland J, Pagano M. Regulation of the Cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183:10–17.10.1002/(ISSN)1097-4652
   PubMed Web of Science ®Google Scholar
• Lee YS, Mulugu S, York JD, et al. Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates. Science. 2007;316:109–112.10.1126/science.1139080
   PubMed Web of Science ®Google Scholar
• Lee YS, Huang K, Quiocho FA, et al. Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate. Nat Chem Biol. 2008;4:25–32.10.1038/nchembio.2007.52
   PubMed Web of Science ®Google Scholar
• Hu CD, Chinenov Y, Kerppola TK. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 2002;9:789–798.10.1016/S1097-2765(02)00496-3
   PubMed Web of Science ®Google Scholar
• Grinberg AV, Hu CD, Kerppola TK. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol Cell Biol. 2004;24:4294–4308.10.1128/MCB.24.10.4294-4308.2004
   PubMed Web of Science ®Google Scholar
• Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol. 2004;6:358–365.10.1038/ncb1113
   PubMed Web of Science ®Google Scholar
• Arabi A, Wu S, Ridderstrale K, et al. C-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005;7:303–310.10.1038/ncb1225
   PubMed Web of Science ®Google Scholar
• Jakoby MJ, Weinl C, Pusch S, et al. Analysis of the subcellular localization, function, and proteolytic control of the arabidopsis cyclin-dependent kinase inhibitor ICK1/KRP1. Plant Physiol. 2006;141:1293–1305.10.1104/pp.106.081406
   PubMed Web of Science ®Google Scholar
• Qi Q, Sahu N, August A. Tec kinase itk forms membrane clusters specifically in the vicinity of recruiting receptors. J Biol Chem. 2006;281:38529–38534.10.1074/jbc.M609180200
   PubMed Web of Science ®Google Scholar
• Wang KZ, Wara-Aswapati N, Boch JA, et al. TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src. J Cell Sci. 2006;119:1579–1591.10.1242/jcs.02889
   PubMed Web of Science ®Google Scholar
• Chibazakura T, McGrew SG, Cooper JA, et al. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc Natl Acad Sci USA. 2004;101:4465–4470.10.1073/pnas.0400655101
   PubMed Web of Science ®Google Scholar
• Turner DL, Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 1994;8:1434–1447.10.1101/gad.8.12.1434
   PubMed Web of Science ®Google Scholar
• Clurman BE, Sheaff RJ, Thress K, et al. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 1996;10:1979–1990.10.1101/gad.10.16.1979
   PubMed Web of Science ®Google Scholar
• Marraccino RL, Firpo EJ, Roberts JM. Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol Biol Cell. 1992;3:389–401.10.1091/mbc.3.4.389
   PubMedGoogle Scholar
• Russo AA, Jeffrey PD, Patten AK, et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature. 1996;382:325–331.10.1038/382325a0
   PubMed Web of Science ®Google Scholar